E0302 (mecobalamin)

DRUG2 trials

Sponsors

Eisai Co., Ltd.

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Phase 2

A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT00445172

Eisai Co., Ltd.Amyotrophic Lateral Sclerosis (ALS)

Start: 2008-02-29End: 2017-03-31Updated: 2023-06-18

A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT00444613

Eisai Co., Ltd.Amyotrophic Lateral Sclerosis (ALS)

Start: 2007-04-30End: 2014-07-31Updated: 2023-06-18

Related Papers

Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study

Journal of Neurology Neurosurgery & Psychiatry2019-01-1375 citations

Neuroprotective effect of ultra-high dose methylcobalamin in wobbler mouse model of amyotrophic lateral sclerosis.

2015-05-0828 citations